Results 81 to 90 of about 8,134 (194)

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial

open access: yesBMC Gastroenterology, 2020
Background To determine the safety and efficacy of different doses of tolvaptan for treating Chinese cirrhotic patients with or without hyponatraemia who still had ascites after routine therapy with diuretics.
Jieting Tang   +19 more
doaj   +1 more source

The Association of Hyponatremia with Race, Ethnicity, and Gender in Patients Admitted for Acute Decompensated Heart Failure Diagnoses [PDF]

open access: yes, 2018
Background: Hyponatremia, defined by a serum sodium concentration less than 135 mEq/L, is seen in approximately 25% of patients admitted with congestive heart failure (CHF).
Alvarez, MD, Rene   +2 more
core   +1 more source

Stability of Medications Administered via Enteral Feeding Tubes: A Systematic Review

open access: yesClinical and Translational Science, Volume 19, Issue 1, January 2026.
The graphical abstract for the stability of medicatioins administred via enteral feeding tube: A systematic review ((PROSPERO, registration number: CRD42024580820)). ABSTRACT Feeding tubes are essential for patients unable to maintain adequate oral intake, serving multiple purposes including nutrition delivery and medication administration.
Lena Alodat   +3 more
wiley   +1 more source

Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.

open access: yesPLoS ONE, 2017
AimsSeveral studies reported treatment benefits of tolvaptan in patients with congestive heart failure (CHF). However, the optimal dosage remains unclear.
Mei-Yi Wu   +6 more
doaj   +1 more source

Vasopressin-2 receptor antagonists in autosomal dominant polycystic kidney disease: from man to mouse and back [PDF]

open access: yes, 2016
nephropathy, with an esti-mated prevalence of 1:1000. The disease is characterized by the development of multiple cysts from all nephron segments leading to the enlargement of both kidneys and replacement of normal parenchyma (see [1]).
Devuyst, Olivier   +2 more
core  

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)

open access: yesESC Heart Failure, 2020
Aims Hyponatremia is associated with poorer outcomes and diuretic response in patients hospitalized for heart failure. This study compared a tolvaptan‐based vs.
Tien M.H. Ng   +9 more
doaj   +1 more source

Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study [PDF]

open access: yes, 2018
BACKGROUND Previous in vitro experiments of human polycystic kidney disease (PKD) cells reported that caffeine is a risk factor for the promotion of cyst enlargement in patients with autosomal dominant PKD (ADPKD).
Braun, Julia   +3 more
core   +1 more source

L\u2019IPONATRIEMIA NELL\u2019ANZIANO: UNA PROBLEMATICA SEMPRE ATTUALE [PDF]

open access: yes, 2015
Le alterazioni della concentrazione plasmatica del sodio rappresentano una delle disionie di pi\uf9 frequente riscontro nei pazienti ricoverati e che l\u2019incidenza e la prevalenza aumentano con l\u2019et\ue0.
Barbagallo, M.   +2 more
core  

Short term efficacy and safety of low dose tolvaptan in patients with acute decompensated heart failure with hyponatremia: a prospective observational pilot study from a single center in South India

open access: yesHeart Views, 2014
Background: In acute decompensated heart failure (ADHF), diuretic use, the mainstay therapy for congestion, is associated with electrolyte abnormalities and worsening renal function. Vasopressin mediates fluid retention in heart failure.
Soumya Patra   +10 more
doaj   +1 more source

SEOM guidelines on hydroelectrolytic disorders [PDF]

open access: yes, 2014
Hydroelectrolytic disorders are one of the most common metabolic complications in cancer patients. Although often metabolic alterations affecting various ions are part of the manifestations of the oncological disease, even in the form of paraneoplastic ...
A. Blasco   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy